{"id":8,"date":"2022-06-24T18:30:17","date_gmt":"2022-06-24T18:30:17","guid":{"rendered":"https:\/\/www.msd.com\/india\/?page_id=8"},"modified":"2025-08-06T04:44:43","modified_gmt":"2025-08-06T04:44:43","slug":"about-us","status":"publish","type":"page","link":"https:\/\/www.msd.com\/india\/","title":{"rendered":"About Us"},"content":{"rendered":"\n
\n
\n
\n\n
\n \n\t\n\n\n\n\t\"\"\n<\/picture> <\/div>\n
\n <\/div>\n <\/div>\n\n
\n \n

IMPROVING HEALTH IMPROVING LIVES<\/h1>\n \n \n <\/div>\n <\/div>\n\n \n<\/div>\n\n\n\n

About Us<\/strong><\/span><\/h2>\n\n\n\n

MSD India Board of Directors<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Rehan A. Khan<\/strong><\/p>\n\n\n\n

Managing Director, MSD India Region<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Chand Berry<\/strong><\/p>\n\n\n\n

Director \u2013 Finance<\/p>\n<\/div>\n\n\n\n

\n

<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n

MSD India Leadership Team<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Rehan A. Khan<\/strong><\/p>\n\n\n\n

Managing Director, MSD India Region<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Neelima Dwivedi<\/strong><\/p>\n\n\n\n

Senior Director – Public Policy, Corporate Communications & Market Access<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Bhargavi Kakunuri<\/strong><\/p>\n\n\n\n

Director \u2013 Human Resources<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Chand Berry<\/strong><\/p>\n\n\n\n

Director \u2013 Finance<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Saurav Patyal<\/strong><\/strong><\/p>\n\n\n\n

Director – Oncology<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Dr. Monisha Sharma<\/strong><\/p>\n\n\n\n

Clinical Research Director – India, Philippines & Vietnam, Global Clinical Trial Operations<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n\n\n\n

Dr. Mamta Singh<\/strong><\/p>\n\n\n\n

Director \u2013 Regulatory Affairs<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

Sachin Sable<\/strong><\/p>\n\n\n\n

Supply Chain Execution Lead \u2013 South Asia (India, ANZ, SGMY & Indonesia)<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

Alok Kumar Sengupta<\/strong><\/p>\n\n\n\n

Director – Business Development Asia Pacific<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Manjunath Moodbidri<\/strong><\/strong><\/p>\n\n\n\n

Business Technology Partner \u2013 India, Singapore, Malaysia, Vietnam and Indonesia<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Ravindra Sangam<\/strong><\/p>\n\n\n\n

Director \u2013 Strategic Alliances, Asia Pacific<\/p>\n<\/div>\n\n\n\n

\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n

Contact us<\/strong><\/span><\/h2>\n\n\n\n

MSD in India<\/h3>\n\n\n\n

Registered Office:<\/strong>
1544, Level 15, Eros Corporate Towers, Nehru Place, New Delhi- 110019<\/p>\n\n\n\n

Communication Office:<\/strong>
WeWork Enam Sambhava, 7th, 8th and 9th floor, C-20, G Block, Bandra Kurla Complex, Bandra East, Mumbai \u2013 400051
Tel: +91 22 67898888 I Fax: +91 22 67898889
Toll free number: 18001032642
For Media & Communications:<\/strong> media_india@msd.com<\/a><\/p>\n\n\n\n

English :<\/strong><\/p>\n\n\n\n

 To report an adverse experience related to MSD product, email us at dpoc_india@msd.com<\/a><\/p>\n\n\n\n

Hindi:<\/strong><\/p>\n\n\n\n

\u092f\u0926\u093f \u0906\u092a MSD \u0909\u0924\u094d\u092a\u093e\u0926 \u0938\u0947 \u0938\u0902\u092c\u0902\u0927\u093f\u0924 \u0915\u093f\u0938\u0940 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u0905\u0928\u0941\u092d\u0935 \u0915\u094b \u0930\u093f\u092a\u094b\u0930\u094d\u091f \u0915\u0930\u0928\u093e \u091a\u093e\u0939\u0924\u0947 \u0939\u0948\u0902- \u092f\u0939\u093e\u0902 \u0915\u094d\u0932\u093f\u0915 \u0915\u0930\u0947\u0902<\/a><\/p>\n\n\n\n

Bengali<\/strong><\/p>\n\n\n\n

\u0986\u09aa\u09a8\u09bf \u09af\u09a6\u09bf \u0995\u09cb\u09a8\u0993 \u098f\u09ae\u098f\u09b8\u09a1\u09bf \u09aa\u09a3\u09cd\u09af \u09b8\u09ae\u09cd\u09aa\u09b0\u09cd\u0995\u09c7 \u098f\u0995\u099f\u09bf \u09a8\u09c7\u09a4\u09bf\u09ac\u09be\u099a\u0995 \u0985\u09ad\u09bf\u099c\u09cd\u099e\u09a4\u09be \u09b0\u09bf\u09aa\u09cb\u09b0\u09cd\u099f \u0995\u09b0\u09a4\u09c7 \u099a\u09be\u09a8 \u09a4\u09ac\u09c7 \u098f\u0996\u09be\u09a8\u09c7 \u0995\u09cd\u09b2\u09bf\u0995 \u0995\u09b0\u09c1\u09a8<\/a><\/p>\n\n\n\n

Tamil<\/strong><\/p>\n\n\n\n

\u0ba8\u0bc0\u0b99\u0bcd\u0b95\u0bb3\u0bcd, \u0b92\u0bb0\u0bc1 MSD \u0ba4\u0baf\u0bbe\u0bb0\u0bbf\u0baa\u0bcd\u0baa\u0bc1 \u0b95\u0bc1\u0bb1\u0bbf\u0ba4\u0bcd\u0ba4 \u0bae\u0bcb\u0b9a\u0bae\u0bbe\u0ba9 \u0b85\u0ba9\u0bc1\u0baa\u0bb5\u0ba4\u0bcd\u0ba4\u0bc8 \u0baa\u0bc1\u0b95\u0bbe\u0bb0\u0bcd \u0b9a\u0bc6\u0baf\u0bcd\u0baf \u0bb5\u0bc7\u0ba3\u0bcd\u0b9f\u0bc1\u0bae\u0bc6\u0ba9\u0bbf\u0bb2\u0bcd – \u0b87\u0b99\u0bcd\u0b95\u0bc1 \u0b95\u0bbf\u0bb3\u0bbf\u0b95\u0bcd \u0b9a\u0bc6\u0baf\u0bcd\u0baf\u0bb5\u0bc1\u0bae\u0bcd.<\/a><\/p>\n\n\n\n

Marathi<\/strong><\/p>\n\n\n\n

\u090f\u092e\u090f\u0938\u0921\u0940 \u0909\u0924\u094d\u200d\u200d\u200d\u200d\u200d\u200d\u200d\u092a\u093e\u0926\u0928\u093e\u0936\u0940 \u0938\u0902\u092c\u0902\u0927\u093f\u0924 \u0915\u094b\u0923\u0924\u093e\u0939\u0940 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u0905\u0928\u0941\u092d\u0935 \u0924\u0941\u092e\u094d\u200d\u0939\u093e\u0932\u093e \u0938\u093e\u0902\u0917\u093e\u092f\u091a\u093e \u0905\u0938\u0947\u0932 \u0924\u0930 – \u092f\u0947\u0925\u0947 \u0915\u094d\u0932\u093f\u0915 \u0915\u0930\u093e<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\tFor healthcare professionals<\/a>\n\n\n\n\n

\n
\n
\n
\n

Disclaimer:<\/h3>\n <\/header>\n
\n

By clicking on the following link that leads me to the drug-specific SMPC\/PI, I understand the following:<\/p>\n

    \n
  1. The information contained in this link is for the sole purpose of use and knowledge of RMPs only and intended to guide such RMPs in respect of matters relating to (a) therapeutic indication of the respective drug (b) its administration (c) its dosage\u00a0 (d) its side-effects and (e) the precautions to be observed in the treatment with the drugs<\/li>\n
  2. These SMPC\/PI are drug-specific technical documents that are part of every medicine’s marketing authorization. MSD has made them available on this website on the instructions of the relevant regulatory authorities, and nothing provided therein should be construed as medical advice.<\/li>\n
  3. Patients and their relatives should not access the information contained in this link and they are advised to consult their treating physicians.<\/li>\n<\/ol>\n <\/div>\n